Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
B
B
Bourre
R
R
Lefaucheur
C
C
Girault
D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D009471:Neuromyelitis Optica / Q000628:therapy*; D010951:Plasma Exchange / Q000009:adverse effects; D012008:Recurrence; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab